Gain access to actionable insights from our expert analysts

Our teams of experienced healthcare analysts produce regular whitepapers on the issues and trends affecting the pharmaceutical and medical device markets, and offer complimentary trend reports, factsheets and sample reports from across our wide portfolio. Request your free copy of any of the content below to gain access to valuable data, analysis and expert opinion.

  1. Healthcare whitepaper

    Drug Availability and Access in Australia – Government and Big Pharma Playing the Blame Game

    In this whitepaper, GlobalData discusses the recent pledge by the Australian government to invest in healthcare to improve access to life-saving medicines for the Australian people and provides independent insight into the merits and faults of Medicare and the Pharmaceuticals Benefits Scheme (PBS).

  2. Healthcare whitepaper

    Arena International's Clinical Trials Yearbook 2017 in association with GlobalData

    In this whitepaper, GlobalData's healthcare research features prominently in Arena International's Clinical Trials Yearbook 2017, providing robust insight into current and anticipated trends in the drug development space. It includes GlobalData's five-year retrospective analysis of terminated clinical trials.

  3. Healthcare whitepaper

    Top 10 Trends in Medical Devices in 2017

    In this whitepaper, GlobalData discusses the ten major trends it believes will greatly influence the direction of the global medical technology markets in 2017, including the rise of bolt-on acquisitions, the decline of venture capital, and the boom in robo-assisted procedures.

  4. Healthcare whitepaper

    AbbVie Increases Pressure on Gilead: The AASLD Meeting 2016 and the Push to Cure Every HCV Patient

    In this whitepaper, GlobalData discusses presentations from this year's annual meeting of the American Society for the Study of Liver Disease (AASLD), and what the future treatment landscape might look like for patients suffering from chronic HCV infections.

  5. Healthcare whitepaper

    Post-Brexit Fall-Out for the UK Pharma and Medical Device Industries

    In this whitepaper, GlobalData discusses the major challenges faced by the UK pharmaceutical and medical device industries following the UK’s referendum, in which a clear majority of voters indicated their desire for the UK to leave the European Union. It provides analysis of the impact of this outcome on five key areas, including regulatory impacts, research and development, access to talent, intellectual property rights and market access.

×

© GlobalData 2017. John Carpenter House, 7 Carmelite Street, London EC4 0BS.